RIVM is a Dutch public authority that focuses on promoting public health and safeguarding environmental quality. It has roles in the regulatory system for medicines regarding Environmental Risks Assessments (Caroline Moermond), Chemical-Pharmaceutical quality (Bastiaan Venhuis), Pharmaco-economics and also carries out Life Cycle Analyses in the healthcare domain. RIVM has been involved in related projects as PREMIER.
Role in the project
Headed by Dr. Bastiaan Venhuis, RIVM is involved in WP2-6 and they will be leading the WP5 and developing activities as filling data gaps in LCI, developing methodology to compare pharmaceutical ingredients and products (WP4, business case studies for greener pharmaceuticals (WP5), and education modules (WP6).